### Comment:
A buddy of mine is in healthcare ER at Cowen and he straight up said most biotech equity research is super speculative and is quite literally bullshit. This mainly pertains to early stage and some midcap biotechs, but still, damn.

### REPLY:
Damn. Well with that DD.

### END.